Peng, L., Chen, Y., Chen, T., Hu, X., Chen, J., Zhang, J., Yong, J., Huang, P., Xu, Y., Li, Y., Ye, C., Chen, X., Fang, X., Liu, J. (2026). Neoadjuvant systemic chemotherapy combined with camrelizumab (CAM) and apatinib (APA) for BCLC stage A/B hepatocellular carcinoma (HCC) beyond Milan criteria: An interim analysis of a phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16283